文献速递心血管腹部CTUS

代谢功能障碍相关脂肪性肝病对冠状动脉斑块特征及生理状态的影响:一项冠状动脉CT血管成像研究

The Impact of MAFLD on Coronary Plaque Characteristics and Physiologic Status: A Coronary CT Angiography Study.
PubMed 文献 · Acad Radiol · 2024-11-15

前瞻性纳入203例疑似冠心病、接受冠状动脉CT血管成像和腹部超声的受试者(共728个斑块),分为MAFLD组与非MAFLD组。MAFLD组斑块坏死核心体积更高,阻塞性冠心病、SIS>4、高危斑块及FFRCT≤0.8的比例均更高,且MAFLD可独立于传统心血管危险因素预测上述指标。

要点

  • MAFLD患者阻塞性冠心病比例35.9% vs 非MAFLD 21.6%(p=0.026)。
  • MAFLD组高危斑块55.1% vs 非MAFLD组29.6%(p<0.001)。
  • MAFLD组FFRCT≤0.8比例33.3% vs 非MAFLD组15.2%(p=0.002)。

核心结论

  • MAFLD与CCTA所示的斑块特征相关,包括冠心病严重程度与范围、高危斑块及生理状态,且独立于传统危险因素。

研究设计与样本

  • 前瞻性研究,共纳入203例疑似冠心病受试者(含728个斑块),均接受CCTA与腹部超声检查,分为MAFLD组与非MAFLD组。

关键影像表现/征象

  • MAFLD组坏死核心斑块体积在受试者水平(p<0.001)和斑块水平(p=0.001)均高于非MAFLD组。
  • MAFLD组阻塞性冠心病、SIS>4、高危斑块及FFRCT≤0.8的患病率均高于非MAFLD组。

诊断标准与关键数值

  • 阻塞性冠心病:MAFLD组35.9% vs 非MAFLD组21.6%(p=0.026)。
  • SIS>4:MAFLD组39.7% vs 非MAFLD组17.6%(p<0.001)。
  • 高危斑块:MAFLD组55.1% vs 非MAFLD组29.6%(p<0.001)。
  • FFRCT≤0.8:MAFLD组33.3% vs 非MAFLD组15.2%(p=0.002)。
  • MAFLD预测阻塞性冠心病调整OR 2.44(95%CI 1.22-4.87,p=0.011)、SIS>4调整OR 3.64(95%CI 1.78-7.46,p<0.001)、高危斑块调整OR 2.52(95%CI 1.37-4.63,p=0.003)、FFRCT≤0.8调整OR 3.53(95%CI 1.65-7.57,p=0.001)。

临床应用与阅片要点

  • 对疑似冠心病患者行CCTA时,若已知合并MAFLD,阅片应关注斑块坏死核心体积、高危斑块特征及FFRCT≤0.8等功能学指标。
  • MAFLD患者中阻塞性冠心病、SIS>4、高危斑块及FFRCT≤0.8的患病率更高,报告时可结合临床提示临床关注。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Metabolic dysfunction-associated fatty liver disease (MAFLD) is linked to an increased risk of cardiovascular events. Our study sought to determine the impact of MAFLD on both the anatomy and function of coronary plaques.

MATERIALS AND METHODS: A total of 203 participants (including 728 plaques) with suspected coronary artery disease (CAD) who underwent coronary CT angiography (CCTA) and abdominal ultrasound were prospectively enrolled. Participants were divided into MAFLD and non-MAFLD groups. For each plaque, necrotic core plaque volume and fractional flow reserve derived from CT (FFRCT) were measured. Obstructive CAD, segment involvement score (SIS) >4, high-risk plaque (HRP) and FFRCT ≤ 0.8 were assessed.

RESULTS: Compared to non-MAFLD, necrotic core plaque volume was higher in MAFLD at both participant level (p < 0.001) and plaque level (p = 0.001). MAFLD had a higher prevalence of obstructive CAD, SIS >4, HRP and FFRCT ≤ 0.8 at participant level (obstructive CAD: 35.9% vs 21.6%, p = 0.026; SIS >4: 39.7% vs 17.6%, p < 0.001; HRP: 55.1% vs 29.6%, p < 0.001; FFRCT ≤0.8: 33.3% vs 15.2%, p = 0.002). In addition, MAFLD predicted the presence of obstructive CAD (adjusted OR: 2.44; 95% CI: 1.22-4.87; p = 0.011), SIS >4 (adjusted OR: 3.64; 95% CI: 1.78-7.46; p < 0.001), HRP (adjusted OR: 2.52; 95% CI: 1.37-4.63; p = 0.003) and FFRCT ≤ 0.8 (adjusted OR: 3.53; 95% CI: 1.65-7.57; p = 0.001) independent of traditional cardiovascular risk factors.

CONCLUSION: MAFLD is associated with CCTA derived plaque characteristics, including the severity and extent of CAD, HRP, as well as physiologic status, independent of traditional risk factors.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Liu Q, Zheng XD, Xiao YY, et al. The Impact of MAFLD on Coronary Plaque Characteristics and Physiologic Status: A Coronary CT Angiography Study. Acad Radiol. 2024. PMID: 39550345. doi:10.1016/j.acra.2024.10.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。